ISpecimen Analyst Ratings
ISpecimen Analyst Ratings
While ratings are subjective and will change, the latest iSpecimen (ISPC) rating was a initiated with a price target of $0.00 to $20.00. The current price iSpecimen (ISPC) is trading at is $1.87, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/23/2022 | 127.27% | EF Hutton | $5.5 → $4.25 | Maintains | Buy |
| 01/04/2022 | 969.52% | Craig-Hallum | → $20 | Initiates Coverage On | → Buy |
| 11/22/2021 | 541.71% | EF Hutton | $10 → $12 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 09/23/2022 | 127.27% | EF Hutton | 5.5 美元 → 4.25 美元 | 維護 | 買 |
| 2022 年 4 月 1 日 | 969.52% | Craig-Hallum | → 20 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 11/22/2021 | 541.71% | EF Hutton | 10 美元 → 12 美元 | 維護 | 買 |
iSpecimen Questions & Answers
iSpecimen 問題與解答
The latest price target for iSpecimen (NASDAQ: ISPC) was reported by Craig-Hallum on January 4, 2022. The analyst firm set a price target for $20.00 expecting ISPC to rise to within 12 months (a possible 969.52% upside). 2 analyst firms have reported ratings in the last year.
克雷格-哈勒姆於2022年1月4日公佈了iSpecimen（納斯達克股票代碼：ISPC）的最新目標股價。該分析公司將目標股價定爲20.00美元，預計ISPC將在12個月內升至12個月內（可能上漲969.52％）。去年有2家分析公司公佈了評級。
The latest analyst rating for iSpecimen (NASDAQ: ISPC) was provided by Craig-Hallum, and iSpecimen initiated their buy rating.
iSpecimen（納斯達克股票代碼：ISPC）的最新分析師評級由Craig-Hallum提供，ispecimen啓動了買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iSpecimen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iSpecimen was filed on January 4, 2022 so you should expect the next rating to be made available sometime around January 4, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與iSpecimen的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。iSpecimen的最新評級是在2022年1月4日發佈的，因此您應該預計下一個評級將在2023年1月4日左右公佈。
While ratings are subjective and will change, the latest iSpecimen (ISPC) rating was a initiated with a price target of $0.00 to $20.00. The current price iSpecimen (ISPC) is trading at is $1.87, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的iSpecimen（ISPC）評級是啓動的，目標股價爲0.00美元至20.00美元。iSpecimen（ISPC）目前的交易價格爲1.87美元，在分析師的預測區間內。